How a Salmonella Infection Hid Inside a Toddler’s Brain Until Genetic Sequencing Caught It

When a one-year-old girl arrived at a Chinese hospital with fever and signs of central nervous system inflammation, her doctors faced one of pediatrics’ most stubborn diagnostic puzzles. The child, just thirteen months old, was eventually diagnosed with purulent meningitis combined with sepsis caused by Salmonella group D, a bacterium better known for causing gastrointestinal upset than for invading the brain. Her case, reported in BMC Pediatrics by Weiping Li, Huafeng Zhao, Qingxia Zhou, and Xiaojie Guo of Weifang People’s Hospital affiliated with Shandong Second Medical University, took a winding course that required three separate hospitalizations before clinicians finally brought the infection under control. What makes the report remarkable is not just the rarity of the pathogen involved, but the hard-won technical lessons it offers about how modern molecular diagnostics can catch what conventional testing misses.

Salmonella is a genus of rod-shaped, Gram-negative bacteria encompassing more than 2,500 serotypes, traditionally divided into typhoidal and non-typhoidal varieties. Typhoidal serotypes, such as Salmonella Typhi, cause typhoid fever, while non-typhoidal Salmonella, often abbreviated NTS, typically trigger self-limiting gastroenteritis in healthy people. Yet in infants, the elderly, and the immunocompromised, NTS can turn invasive, spreading from the intestinal lining into the bloodstream and, far less commonly, crossing the blood-brain barrier to seed the meninges, the protective membranes surrounding the brain and spinal cord. Salmonella meningitis in children is genuinely rare, and the authors note that reports of sepsis and purulent meningitis caused by Salmonella in pediatric patients are very scarce in the literature. That rarity is precisely what makes the diagnosis so easy to miss on a first pass.

The girl’s illness followed a recurrent pattern that initially confounded her care team. She was hospitalized three times over the course of her disease, and the authors are candid that the first round of anti-infective treatment was insufficient in both intensity and duration. When invasive bacterial infections are treated with antibiotics that are too brief, too narrow, or inadequately dosed, the pathogen can persist at low levels within protected anatomical compartments, only to flare again once the drug pressure is removed. The meninges, with their restricted penetration by many antimicrobial agents, are a classic sanctuary site for surviving bacteria. Each relapse in this child’s course was a signal that the underlying infection had never been fully eradicated, a mistake the authors explicitly frame as a lesson for other clinicians managing similar presentations.

Getting to the correct etiologic answer required layering multiple diagnostic technologies. Cerebrospinal fluid, the clear liquid bathing the brain and spinal cord, was sampled via lumbar puncture and subjected to both traditional pathogen culture and metagenomic next-generation sequencing, abbreviated mNGS. Culture, the workhorse of clinical microbiology for more than a century, involves growing the organism on selective media and identifying it biochemically, but it can fail when bacterial loads are low, when the patient has already received antibiotics, or when the organism is fastidious. mNGS, by contrast, works by extracting all genetic material from a clinical sample, sequencing it in parallel, and computationally matching the resulting reads against reference databases of known pathogens. This approach can identify bacteria, viruses, fungi, and parasites directly from their DNA without needing to grow anything, making it especially powerful in cases where prior antimicrobial exposure has suppressed culturability.

The mNGS results from the child’s cerebrospinal fluid pointed to Salmonella group D, a serogroup that includes Salmonella Enteritidis and Salmonella Typhi among its members. Confirmatory culture from the same fluid grew the organism, and the clinicians added a serologic layer by performing a Widal test, a classic agglutination assay that detects antibodies against Salmonella O and H antigens in the patient’s serum. The H/O antibody titer came back at 1:320, a level the authors considered supportive of active Salmonella infection when interpreted alongside the molecular and cultural findings. The Widal test, developed in 1896, remains in widespread use in resource-limited settings, though its specificity is limited by cross-reactivity with other Enterobacteriaceae and by residual antibodies from prior exposure or vaccination. In this case, the convergence of three independent lines of evidence, molecular, cultural, and serologic, gave the team the confidence to commit to a targeted therapeutic strategy.

Treating Salmonella meningitis is pharmacologically tricky because the organism’s susceptibility profile varies by serotype and geography, and because the drugs must penetrate the blood-brain barrier in sufficient concentrations. The clinicians tried ceftriaxone, a third-generation cephalosporin that is often first-line for invasive Salmonella disease in children, then escalated to vancomycin, a glycopeptide active against Gram-positive organisms but sometimes added empirically when the pathogen remains unclear, and meropenem, a broad-spectrum carbapenem with excellent central nervous system penetration. When the infection proved stubborn, they added compound sulfamethoxazole, a combination of sulfamethoxazole and trimethoprim that achieves reliable intracellular and cerebrospinal fluid exposure. The authors emphasize that resistance assessment, meaning formal antimicrobial susceptibility testing of the isolated organism, should be a routine part of managing invasive Salmonella infections, since resistance patterns among non-typhoidal Salmonella have been rising globally and can render empiric choices ineffective.

Ultimately, what turned the tide was not a single new drug but a combination of extended anti-infective treatment courses and immune support. The authors argue that clinicians should monitor the immune status of children with invasive Salmonella disease, because an immature or dysregulated immune system can undermine even the most pharmacologically sound regimen. Infants have naturally lower levels of certain immunoglobulins and complement proteins, and their neutrophil function is not yet fully mature, which means that bacterial clearance depends heavily on adequate antibiotic exposure over a sufficiently long period. By prolonging the antimicrobial course and layering in immune-supportive measures, the team finally achieved durable control of the infection, and the child’s condition stabilized. The authors do not report long-term neurologic sequelae in the abstract, leaving that question open for follow-up, but the acute episode was resolved.

The case carries broader implications for how pediatric infectious disease is approached in the era of molecular diagnostics. The authors conclude that treatment plans should be dynamically adjusted as new information arrives, rather than locked into a fixed empiric protocol, and that mNGS should be combined with conventional techniques to accurately identify pathogens in complicated cases. This is a message that resonates well beyond Salmonella. As sequencing costs fall and turnaround times shrink, metagenomic approaches are increasingly being deployed as first-line tools in unexplained fevers, suspected central nervous system infections, and sepsis of unknown origin, particularly in children where the differential diagnosis is broad and the cost of a missed pathogen is high. The technology is not without limitations, including the risk of detecting contaminants, the difficulty of distinguishing colonization from infection, and the computational burden of analyzing millions of reads, but its ability to shortcut the diagnostic odyssey is transforming clinical practice.

For clinicians, the takeaway from this single child’s illness is a checklist of three technical priorities: perform rigorous drug resistance assessment on any invasive Salmonella isolate, ensure that anti-infective treatment courses are adequate in both duration and intensity rather than prematurely shortened, and monitor the patient’s immune status throughout the disease course. For the wider scientific community, the case is a vivid demonstration that rare pathogens can masquerade as common ones, that conventional diagnostics can fail in the very situations where they are needed most, and that molecular sequencing, when layered thoughtfully with culture and serology, can catch what would otherwise slip through. The authors thank the patient and her parents for permission to publish the case, and their candor about the initial treatment missteps is what gives the report its enduring value as a teaching document for pediatricians everywhere.

Subject of Research: Infectious Diseases

Article Title: Purulent meningitis caused by salmonella group D in a one-year-old child: lessons learned from mistakes

Article References: Li, W., Zhao, H., Zhou, Q., & Guo, X. (2026). Purulent meningitis caused by salmonella group D in a one-year-old child: lessons learned from mistakes. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07620-w

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07620-w

Keywords: Salmonella, meningitis, sepsis, mNGS, pediatrics, antibiotic resistance, case report, Purulent, caused, group, one-year-old, child